The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Epidemiology of male breast cancer
Open accessAbstract
BACKGROUND: Due to its rarity, few studies have characterized the epidemiology of male breast cancer. The purpose of this study was to determine survival and risk factors for male breast cancer in a large U.S. METHODS: In this study, 19,795 male patients with breast cancer were identified from the National Cancer Database (2004-2014). Patient demographics, tumor characteristics and treatments were analyzed by using descriptive statistics. We used multivariate Cox regression and Kaplan Meier analysis. RESULTS: Over 10 years, the incidence of male breast cancer increased from 7.2% to 10.3%, while mortality decreased from 11% to 3.8%. Socioeconomic factors predicting mortality included income medium, and high vs low (HR = 0.78; 0.68), private vs no insurance (HR = 0.73) and the academic research facility vs community cancer center (HR = 0.79). Significant predictors of all-cause mortality included age (HR = 1.04), tumor size (HR = 1.01), hormone receptor expression (HR = 0.8) and cancer stage I vs II, III, and IV at the time of diagnosis (HR = 1.5, 2.7, 4.4, 9.9 respectively). Other predictors of mortality include surgery (HR = 0.4), chemotherapy (HR = 0.8), radiation (HR = 0.8), and hormonal therapy (HR-0.8). CONCLUSIONS: Socioeconomic factors, cancer stage, tumor characteristics (size and grade), and high Charlson-Dayo score contributed to higher mortality among male patients diagnosed with breast cancer. Surgery was most effective, followed by radiation, chemotherapy, and hormonal therapy. Patients with positive ER or PR expression demonstrated better survival. Adjusting for socioeconomic factors, biomarker identification and timely, appropriately chosen treatment are likely to reduce the risk for mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Breast cancer statistics, 2019
DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,114
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Ma, J., & Jemal, A. (2013) · Breast Cancer Metastasis and Drug Resistance · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,907
Lindahl, T., & Wood, R. D. (1999) · Science · doi:10.1126/science.286.5446.1897 · Cited by 1,494
Sampling Methods for Random Digit Dialing
Waksberg, J. (1978) · Journal of the American Statistical Association · doi:10.1080/01621459.1978.10479995 · Cited by 1,390
Molecular mechanism of nucleotide excision repair
de Laat, W. L., Jaspers, N. G. J., & Hoeijmakers, J. H. J. (1999) · Genes & Development · doi:10.1101/gad.13.7.768 · Cited by 1,122
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 971
Alcohol and Breast Cancer in Women: A Pooled Analysis of Cohort Studies
Smith-Warner, S. A., Spiegelman, D., Yaun, S.-S., van den Brandt, P. A., Folsom, A. R., Goldbohm, R. A., Graham, S., Holmberg, L., Howe, G. R., Marshall, J. R., et al. (1998) · JAMA · doi:10.1001/jama.279.7.535 · Cited by 941
Frank, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1480 · Cited by 812
Breast carcinoma in men: A population‐based study
Giordano, S. H., Cohen, D. S., Buzdar, A. U., Perkins, G., & Hortobagyi, G. N. (2004) · Cancer · doi:10.1002/cncr.20312 · Cited by 789
Sequential Assembly of the Nucleotide Excision Repair Factors In Vivo
Volker, M., Moné, M. J., Karmakar, P., van Hoffen, A., Schul, W., Vermeulen, W., Hoeijmakers, J. H. J., van Driel, R., van Zeeland, A. A., & Mullenders, L. H. F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00281-7 · Cited by 782
Buxó Rey, J. (1986) · PubMed · Cited by 750
Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10937 · Cited by 727
Role of BRCA2 in Control of the RAD51 Recombination and DNA Repair Protein
Davies, A. A., Masson, J.-Y., McIlwraith, M. J., Stasiak, A. Z., Stasiak, A., Venkitaraman, A. R., & West, S. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00175-7 · Cited by 718
Environmental and chemical carcinogenesis
Wogan, G. N., Hecht, S. S., Felton, J. S., Conney, A. H., & Loeb, L. A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.010 · Cited by 656
Molecular Mechanisms of Estrogen Carcinogenesis
Yager, J. D., & Leihr, J. G. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001223 · Cited by 654
Chapter 4: Estrogens as Endogenous Genotoxic Agents--DNA Adducts and Mutations
Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., & Roy, D. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024247 · Cited by 595
The surveillance, epidemiology, and end results program: a national resource.
Hankey, B. F., Ries, L. A. G., & Edwards, B. K. (1999) · PubMed · Cited by 594
Key, T., & Pike, M. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.44 · Cited by 547
Lind, C., Hochstein, P., & Ernster, L. (1982) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(82)90202-8 · Cited by 530
ELECTRIC POWER USE AND BREAST CANCER: A HYPOTHESIS
STEVENS, R. G. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114569 · Cited by 499
Giordano, S. H., Buzdar, A. U., & Hortobagyi, G. N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-8-200210150-00013 · Cited by 490
Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer
Vahteristo, P., Bartkova, J., Eerola, H., Syrjäkoski, K., Ojala, S., Kilpivaara, O., Tamminen, A., Kononen, J., Aittomäki, K., Heikkilä, P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341943 · Cited by 467
Carey, A. H., Waterworth, D., Patel, K., White, D., Little, J., Novelli, P., Franks, S., & Williamson, R. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.10.1873 · Cited by 463
Cardoso, F., Bartlett, J. M. S., Slaets, L., van Deurzen, C. H. M., van Leeuwen-Stok, E., Porter, P., Linderholm, B., Hedenfalk, I., Schröder, C., Martens, J., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx651 · Cited by 405
Chapter 3: Endogenous Estrogens as Carcinogens Through Metabolic Activation
Yager, J. D. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024245 · Cited by 398
Sasco, A. J., Lowenfels, A. B., & Jong, P. C. M. P.-D. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530403 · Cited by 397
Giordano, S. H. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1707939 · Cited by 390
Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13
Easton, D. F., Steele, L., Fields, P., Ormiston, W., Averill, D., Daly, P. A., McManus, R., Neuhausen, S. L., Ford, D., Wooster, R., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/513891 · Cited by 387
The eukaryotic nucleotide excision repair pathway
Costa, R. (2003) · Biochimie · doi:10.1016/j.biochi.2003.10.017 · Cited by 373
BRCA2 germline mutations in male breast cancer cases and breast cancer families
Couch, F. J., Farid, L. M., DeShano, M. L., Tavtigian, S. V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-123 · Cited by 363
A Review of the Diagnosis and Management of Male Breast Cancer
Giordano, S. H. (2005) · The Oncologist · doi:10.1634/theoncologist.10-7-471 · Cited by 347
Polymorphisms in DNA repair and metabolic genes in bladder cancer
Sanyal, S. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh058 · Cited by 339
de Laat, W. L., Appeldoorn, E., Sugasawa, K., Weterings, E., Jaspers, N. G. J., & Hoeijmakers, J. H. J. (1998) · Genes & Development · doi:10.1101/gad.12.16.2598 · Cited by 333
Assessing the Risk of Breast Cancer
Armstrong, K., Eisen, A., & Weber, B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420807 · Cited by 317
Study of a single BRCA2 mutation with high carrier frequency in a small population.
Thorlacius, S., Sigurðsson, S., Bjarnadóttir, H., Ólafsdóttir, G. H., Jonasson, J. G., Tryggvadóttír, L., Tulinius, H., & Je, E. (1997) · Europe PMC (PubMed Central) · Cited by 294
Savitz, D. A., & Loomis, D. P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117400 · Cited by 291
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.
Friedman, L. S., Gayther, S. A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., Ponder, B. A. J., & Anton‐Culver, H. (1997) · PubMed · Cited by 275
Male Breast Cancer: Epidemiology and Risk Factors
Abdelwahab Yousef, A. J. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.11.002 · Cited by 272
Incidence and Outcome of Male Breast Cancer: An International Population-Based Study
Miao, H., Verkooijen, H. M., Chia, K., Bouchardy, C., Pukkala, E., Larønningen, S., Mellemkjær, L., Czene, K., & Hartman, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8902 · Cited by 271
Serum Hormones and the Alcohol-Breast Cancer Association in Postmenopausal Women
Dorgan, J. F., Baer, D. J., Albert, P. S., Judd, J. T., Brown, E. D., Corle, D. K., Campbell, W. S., Hartman, T. J., Tejpar, A. A., Clevidence, B. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.710 · Cited by 263
Wooster, R., Mangion, J., Eeles, R., Smith, S., Dowsett, M., Averill, D., Barrett-Lee, P., Easton, D. F., Ponder, B. A. J., & Stratton, M. R. (1992) · Nature Genetics · doi:10.1038/ng1092-132 · Cited by 250
Vodicka, P. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh064 · Cited by 249
Feigelson, H. S., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z., & Henderson, B. E. (1998) · PubMed · Cited by 241
Breast Cancer In Men: Risk Factors with Hormonal Implications
Thomas, D. B., Margarita Jimenez, L., McTieman, A., Rosenblatt, K., Stalsberg, H., Stemhagen, A., Douglas Thompson, W., McCrea Curnen, M. G., Satariano, W., Austin, D. F., et al. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116360 · Cited by 229
Symmers, W. S. (1968) · BMJ · doi:10.1136/bmj.2.5597.83 · Cited by 224
Prevalence of Klinefelter's syndrome in male breast cancer patients.
Hultborn, R., Hanson, C., Köpf, I., Verbiené, I., Warnhammar, E., & WEIMARCK, A. (1998) · PubMed · Cited by 218
Occupational Exposure to Electromagnetic Fields and Breast Cancer in Men
Demers, P. A., Thomas, D. B., Rosenblatt, K. A., Jimenez, L. M., McTiernan, A., Stalsberg, H., Stemhagen, A., Thompson, W. D., Curnen, M. G. M., Satariano, W., et al. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116095 · Cited by 217
Overall Mortality After Diagnosis of Breast Cancer in Men vs Women
Wang, F., Shu, X., Meszoely, I., Pal, T., Mayer, I. A., Yu, Z., Zheng, W., Bailey, C. E., & Shu, X.-O. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2803 · Cited by 208
Male Breast Cancer: A Clinicopathologic Study of 97 Cases
HELLER, K. S., ROSEN, P. P., SCHOTTENFELD, D., ASHIKARI, R., & KINNE, D. W. (1978) · Annals of Surgery · doi:10.1097/00000658-197807000-00010 · Cited by 202
Adjuvant systemic therapy for male breast carcinoma
Giordano, S. H., Perkins, G. H., Broglio, K., Garcia, S. G., Middleton, L. P., Buzdar, A. U., & Hortobagyi, G. N. (2005) · Cancer · doi:10.1002/cncr.21526 · Cited by 200
BRCA1 and BRCA2 mutations in a population-based study of male breast cancer
Basham, V. M., Lipscombe, J. M., Ward, J. M., Gayther, S. A., Ponder, B. A., Easton, D. F., & Pharoah, P. D. (2001) · Breast Cancer Research · doi:10.1186/bcr419 · Cited by 191
Male breast cancer in Cowden syndrome patients with germline PTEN mutations
Fackenthal, J. D., Marsh, D. J., Richardson, A.-L., Cummings, S. A., Eng, C., Robinson, B. G., & Olopade, O. I. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.3.159 · Cited by 190
Wu, X. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.505 · Cited by 175
Zhao, L. P., Li, S. S., & Khalid, N. (2003) · The American Journal of Human Genetics · doi:10.1086/375140 · Cited by 172
Risk Factors for Male Breast Cancer—A Case-Control Study from Scandinavia
Ewertz, M., Holmberg, L., Tretli, S., Pedersen, B. V., & Kristensen, A. (2001) · Acta Oncologica · doi:10.1080/028418601750288181 · Cited by 172
Carcinogen-DNA adducts in human breast tissue.
Perera, F. P., Estabrook, A., Hewer, A. J., Channing, K. M., Rundle, A., Mooney, L. A., Whyatt, R. M., & Phillips, D. H. (1995) · PubMed · Cited by 172
Serova, O., Mazoyer, S., Puget, N., Dubois, V., Tonin, P. N., Shugart, Y. Y., Goldgar, D., Narod, S. A., Lynch, H. T., & Lenoir, G. (1997) · PubMed · Cited by 171
Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis
Liu, N., Johnson, K. J., & Ma, C. X. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.06.013 · Cited by 161
Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
Lee, S. B., Kim, S. H., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Jorczak, M. M., Sgroi, D. C., Garber, J. E., Li, F. P., Nichols, K. E., et al. (2001) · PubMed · Cited by 160
Magnetic Fields and Breast Cancer in Swedish Adults Residing near High-Voltage Power Lines
Feychting, M., Forssén, U. M., Rutqvist, L. E., & Ahlbom, A. (1998) · Epidemiology · doi:10.1097/00001648-199807000-00008 · Cited by 151
Xeroderma pigmentosum group A protein loads as a separate factor onto DNA lesions
Rademakers, S., Volker, M., Hoogstraten, D., Nigg, A. L., Moné, M. J., van Zeeland, A. A., Hoeijmakers, J. H. J., Houtsmuller, A. B., & Vermeulen, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5755-5767.2003 · Cited by 149
Haraldsson, K., Loman, N., Zhang, Q., Jóhannsson, Ó. Þ., Olsson, H. L., & Borg, Å. (1998) · PubMed · Cited by 144
Male breast cancer: a review of the literature
Ravandi‐Kashani, F., & Hayes, T. G. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00028-8 · Cited by 142
A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism
Khan, S. G. (2000) · Carcinogenesis · doi:10.1093/carcin/21.10.1821 · Cited by 142
Risk Factors for Male Breast Cancer (United States)
Hsing, A. W., McLaughlin, J. K., Cocco, P., Chien, H. T. C., & Fraumeni, J. F. (1998) · Cancer Causes & Control · doi:10.1023/a:1008869003012 · Cited by 139
Risk Factors for Male Breast Cancer 2
Mabuchi, K., Bross, D., & Kessler, I. I. (1985) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/74.2.371 · Cited by 139
Steroid hormones and endometrial cancer.
Siiteri, P. K. (1978) · PubMed · Cited by 137
Kraft, P. L., Cox, D. G., Paynter, R. A., Hunter, D., & Vivo, I. D. (2005) · Genetic Epidemiology · doi:10.1002/gepi.20061 · Cited by 137
Androgen receptor gene mutation in male breast cancer.
Lobaccaro, J.-M., Lumbroso, S., Belon, C., Galtier-Dereure, F., Bringer, J., Lesimple, T., Namer, M., Cutull, B. F., Pujol, H., & Sultan, C. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.11.1799 · Cited by 135
Brainard, G. C., Kavet, R. I., & Kheifets, L. (1999) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1999.tb00568.x · Cited by 133
The NICHD Women's Contraceptive and Reproductive Experiences Study
Marchbanks, P. A., McDonald, J. A., Wilson, H. G., Burnett, N. M., Daling, J. R., Bernstein, L., Malone, K. E., Strom, B. L., Norman, S. A., Weiss, L. K., et al. (2002) · Annals of Epidemiology · doi:10.1016/s1047-2797(01)00274-5 · Cited by 131
Shen, H., Sturgis, E. M., Khan, S. G., Qiao, Y., Shahlavi, T., Eicher, S. A., Xu, Y., Wang, X., Strom, S. S., Spitz, M. R., et al. (2001) · PubMed · Cited by 130
Breast Cancer in Men: Aspects of Familial Aggregation
Rosenblatt, K. A., Thomas, D. B., McTiernan, A., Austin, M. A., Stalsberg, H., Stemhagen, A., Thompson, W. D., Curnen, M. G. M., Satariano, W. A., Austin, D. F., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.12.849 · Cited by 125
Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China
Shen, M., Berndt, S. I., Rothman, N., DeMarini, D. M., Mumford, J. L., He, X., Bonner, M. R., Tian, L., Yeager, M., Welch, R., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21117 · Cited by 124
Risk factors for male breast cancer in Canada, 1994–1998
Johnson, K. C., Pan, S. Y., & Mao, Y. (2002) · European Journal of Cancer Prevention · doi:10.1097/00008469-200206000-00009 · Cited by 122
Protein complexes in nucleotide excision repair
Araújo, S. J., & Wood, R. D. (1999) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(99)00042-7 · Cited by 119
A case-control study of male breast cancer.
Casagrande, J. T., Hanisch, R., Pike, M. C., Ross, R. K., Brown, J. B., & Henderson, B. E. (1988) · PubMed · Cited by 116
No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer
Dunning, A. M., Healey, C. S., Pharoah, P., Foster, N., Lipscombe, J., Redman, K., Easton, D., Day, N. E., & Ponder, B. A. J. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.340 · Cited by 113
Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer.
Park, J. Y., Park, S. H., Choi, J. E., Lee, S. Y., Jeon, H. S., Ick, S., Kim, C. H., Park, J. H., Kam, S., Park, R. W., et al. (2002) · PubMed · Cited by 112
Blankenburg, S., König, I. R., Mößner, R., Laspe, P., Thoms, K., Krüger, U., Khan, S. G., Westphal, G., Berking, C., Volkenandt, M., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi055 · Cited by 111
Risk of Breast Cancer in Men With Liver Cirrhosis
Sørensen, H. T., Friis, S., Olsen, J. H., Thulstrup, A. M., Mellemkjær, L., Linet, M. S., Trichopoulos, D., Vilstrup, H., & Olsen, J. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00231.x · Cited by 109
Thomas, D. B. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036108 · Cited by 108
Breast Cancer in a Male-to-Female Transsexual: A Case Report
Pritchard, T. J. (1988) · JAMA · doi:10.1001/jama.259.15.2278 · Cited by 108
Greene, M. H. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.1.54 · Cited by 104
Single nucleotide polymorphisms for DNA repair genes in breast cancer patients
Zhang, L., Zhang, Z., & Yan, W. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.047 · Cited by 103
Risk factors for male breast cancer: A Franco‐Swiss case‐control study
Lenfant‐Pejovic, M., Mlika-Cabanne, N., Bouchardy, C., & Auquier, A. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450415 · Cited by 97
Hansen, J. (2000) · American Journal of Industrial Medicine · doi:10.1002/(sici)1097-0274(200004)37:4<349::aid-ajim4>3.0.co;2-l · Cited by 97
Breast cancer in a trans-sexual man receiving hormone replacement therapy
Ganly, I., & Taylor, E. (1995) · British journal of surgery · doi:10.1002/bjs.1800820319 · Cited by 96
DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population
Hu, Z., Wang, Y., Wang, X., Liang, G., Miao, X., Xu, Y., Tan, W., Wei, Q., Lin, D., & Shen, H. (2005) · International Journal of Cancer · doi:10.1002/ijc.20911 · Cited by 95
Donegan, W. L., & Redlich, P. N. (1996) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70443-6 · Cited by 95
A polymorphism in the CYP17 gene is associated with male breast cancer
Young, I., Kurian, K. M., Annink, C. E., Kunkler, I. H., Anderson, V. A., Cohen, B. B., Hooper, M. L., Wyllie, A. H., & Steel, C. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690663 · Cited by 94
Wang, M.-Y., & Liehr, J. G. (1995) · Carcinogenesis · doi:10.1093/carcin/16.8.1941 · Cited by 92
XPC polymorphisms and lung cancer risk
Lee, G. Y., Jang, J., Lee, S. Y., Jeon, H.-S., Kim, K. M., Choi, J. E., Park, J. M., Chae, M. H., Lee, W. K., Kam, S., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20900 · Cited by 90
Giguère, Y., Dewailly, É., Brisson, J., Ayotte, P., Laflamme, N., Demers, A. A., Forest, V., Dodin, S., Robert, J., & Rousseau, F. (2001) · PubMed · Cited by 90
Second Primary Cancers in Men With Prostate Cancer: An Increased Risk of Male Breast Cancer
Karlsson, C. T., Malmer, B., Tavelin, B., & Grönberg, H. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000056706.88960.7c · Cited by 88
Guénel, P., Cyr, D., Sabroe, S., Lynge, E., Merletti, F., Ahrens, W., Baumgardt‐Elms, C., Ménégoz, F., Olsson, H. L., Paulsen, S. M., et al. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000036154.18162.43 · Cited by 87
Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer
Vogel, U. B., Overvad, K., Wallin, H., Tjønneland, A. M., Nexø, B. A., & Raaschou‐Nielsen, O. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.016 · Cited by 85
Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms
Li, S. S., Khalid, N., Carlson, C., & Zhao, L. P. (2003) · Biostatistics · doi:10.1093/biostatistics/4.4.513 · Cited by 83
Genetic Factors in Catechol Estrogen Metabolism in Relation to the Risk of Endometrial Cancer
Doherty, J. A., Weiss, N. S., Freeman, R. J., Dightman, D. A., Thornton, P. J., Houck, J. R., Voigt, L. F., Rossing, M. A., Schwartz, S. M., & Chen, C. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0479 · Cited by 80
Csókay, B., Udvarhelyi, N., Sulyok, Z., et al. (1999) · PubMed · Cited by 79
Case-control study of occupational exposures and male breast cancer.
Cocco, P., Figgs, L. W., Dosemeci, M., et al. (1998) · Occupational and Environmental Medicine · doi:10.1136/oem.55.9.599 · Cited by 77
Erren, T. C. (2001) · Bioelectromagnetics · doi:10.1002/1521-186x(2001)22:5+<::aid-bem1027>3.0.co;2-0 · Cited by 73
In vivo dynamics of chromatin-associated complex formation in mammalian nucleotide excision repair
Moné, M. J., Bernaś, T., Dinant, C., Goedvree, F. A., Manders, E. M. M., Volker, M., Houtsmuller, A. B., Hoeijmakers, J. H. J., Vermeulen, W., & DRIEL, R. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403664101 · Cited by 73
Vodička, P., Kumar, R., Štětina, R., Mušák, Ľ., Souček, P., Haufroid, V., Sasiadek, M. M., Vodičková, Ľ., Naccarati, A., Sedikova, J., et al. (2004) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20055 · Cited by 70
Festa, F., Kumar, R., Sanyal, S., Undén, A. B., Nordfors, L., Lindholm, B., Snellman, E., Schalling, M., Försti, A., & Hemminki, K. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.01.026 · Cited by 70
Male breast cancer is not congruent with the female disease
Fentiman, I. S. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.02.017 · Cited by 69
Ionizing radiation and breast cancer in men (United States)
Thomas, D. B., Rosenblatt, K. A., Jimenez, L. M., et al. (1994) · Cancer Causes & Control · doi:10.1007/bf01830721 · Cited by 65
Somatic genetic alterations inBRCA2-associated and sporadic male breast cancer
Tirkkonen, M., Kainu, T., Loman, N., J�hannsson, �. T., Olsson, H. L., Barkard�ttir, R. B., Kallioniemi, O., & Borg, �. (1999) · Genes Chromosomes and Cancer · Cited by 65
CHEK2 1100delC is not a risk factor for male breast cancer population
Syrjäkoski, K., Kuukasjärvi, T., Auvinen, A. P., & Kallioniemi, O. (2003) · International Journal of Cancer · doi:10.1002/ijc.11384 · Cited by 63
Breast cancer epidemiology, prevention, and early detection
Brewster, A. M., & Helzlsouer, K. J. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00002 · Cited by 53
Alcohol consumption and risk of breast cancer: a multicentre Italian case–control study
Ferraroni, M., Decarli, A., Franceschi, S., & Vecchia, C. L. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00163-4 · Cited by 52
Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancers
Neuhausen, S. L., Dunning, A. M., Steele, L., Yakumo, K., Hoffman, M. D., Szabo, C., Tee, L. J., Baines, C., Pharoah, P. D. P., Goldgar, D. E., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11385 · Cited by 52
CHEK2*1100delC and male breast cancer risk in Israel
Ohayon, T., Gal, I., Baruch, R. G., Szabo, C., & Friedman, E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11603 · Cited by 50
Androgen Receptor Gene Alterations in Finnish Male Breast Cancer
Syrjäkoski, K., HYYTINEN, E.-R., Kuukasjärvi, T., Auvinen, A. P., Kallioniemi, O., Kainu, T., & Koivisto, P. A. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021369508561 · Cited by 47
The relationship between diet and breast cancer in men (United States)
Rosenblatt, K. A., Thomas, D. B., Jimenez, L. M., Fish, B. E., McTiernan, A., Stalsberg, H., Stemhagen, A., Thompson, W. D., Curnen, M. G. M., Satariano, W. A., et al. (1999) · Cancer Causes & Control · doi:10.1023/a:1008808925665 · Cited by 41
Blankenburg, S., König, I. R., Mößner, R., Laspe, P., Thoms, K., Krüger, U., Khan, S. G., Westphal, G., Volkenandt, M., Neumann, C. R., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201296 · Cited by 40
The CAG repeat within the androgen receptor gene in male breast cancer patients
Young, I., Kurian, K. M., MACKENZIE, M. A. F., KUNKLER, I. H., COHEN, B. B., HOOPER, M. L., WYLLIE, A. H., & STEEL, C. M. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.2.139 · Cited by 39
Butterworth, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.3.561 · Cited by 39
Epidemiology of endometrial cancer
Voigt, L. F., & Weiss, N. S. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0867-6_1 · Cited by 38
Breast cancer in brothersCase reports and a review of 30 cases of male breast cancer
Marger, D., Nelson Urdaneta, L., & Fischer, J. J. (1975) · Cancer · Cited by 32
Schlappack, O. K., Braun, O., & Maier, U. (1986) · PubMed · Cited by 25
Breast cancer risk in male alcoholics in Sweden
Weiderpass, E., Ye, W., Adami, H., Vainio, H., Trichopoulos, D., & Nyrén, O. (2001) · Cancer Causes & Control · doi:10.1023/a:1011216502678 · Cited by 24
Savelyeva, L., Claas, A., Gier, S., et al. (1998) · PubMed · Cited by 24
Saijo, M., Matsuda, T., Kuraoka, I., & Tanaka, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.030 · Cited by 19
Survival Disparities in Male Patients With Breast Cancer
Restrepo, D. J., Boczar, D., Huayllani, M. T., Sisti, A., McLaughlin, S. A., Spaulding, A., Parker, A. S., Carter, R. E., Leppin, A. L., & Forte, A. J. (2019) · Anticancer Research · doi:10.21873/anticanres.13764 · Cited by 16
Treatment Outcomes in Male Breast Cancer: A Retrospective Analysis of 161 Patients
Wan, B. A., Ganesh, V., Zhang, L., Sousa, P., Drost, L., Lorentz, J., Vesprini, D., Lee, J., Rakovitch, E., Lu, F., et al. (2018) · Clinical Oncology · doi:10.1016/j.clon.2018.02.026 · Cited by 10
Cited by
Endocrine Disruptor Vinclozolin Induced Epigenetic Transgenerational Adult-Onset Disease
Anway, M. D., Leathers, C., & Skinner, M. K. (2006) · Endocrinology · doi:10.1210/en.2006-0640 · Cited by 555
Male breast cancer: a disease distinct from female breast cancer
Gucalp, A., Traina, T. A., Eisner, J. R., Parker, J. S., Selitsky, S. R., Park, B. H., Elias, A. D., Baskin-Bey, E. S., & Cardoso, F. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4921-9 · Cited by 392
Kamińska, M., Ciszewski, T., Łopacka-Szatan, K., Miotła, P., & Starosławska, E. (2015) · Menopausal Review · doi:10.5114/pm.2015.54346 · Cited by 383
Sex differences in cancer mechanisms
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., et al. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00291-x · Cited by 366
Male infertility as a window to health
Choy, J. T., & Eisenberg, M. L. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.015 · Cited by 331
Metadata
- Authors
- Konduri, S., Singh, M., Bobustuc, G., Rovin, R., & Kassam, A.
- Venue
- The Breast
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 54
- Pages
- 8-14
- ISSN
- 0960-9776 (ISSN-L)
- OpenAlex
- W2998649508
- Cited by
- 411
- References
- 135
- FWCI
- 15.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.